Not just As­traZeneca — CanSi­no Bi­o­log­ics al­so un­veils Phase II da­ta, show­ing an­ti­body and T cell re­sponse

The biotech and in­fec­tious dis­ease world — much of the world, re­al­ly — sat ea­ger­ly an­tic­i­pat­ing the ear­ly Covid-19 vac­cine da­ta As­traZeneca and the Lancet had promised …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.